The Circular RNA Interacts with STAT3, Increasing Its Nuclear Translocation and Wound Repair by Modulating Dnmt3a and

Zhen-Guo Yang1, Faryal Mehwish Awan2, William W Du3

  • 1Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON M4N 3M5, Canada; Institute of Animal Nutrition, Sichuan Agricultural University, 211 Huimin Road, Wenjiang District, Chengdu, 611130 Sichuan, China; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5S 1A8, Canada.

Insights

Circular RNA circ-Amotl1 significantly accelerates skin wound healing by boosting cell repair mechanisms. This discovery offers potential new treatments for impaired wound healing in conditions like diabetes.

Area of Science:

  • Molecular Biology
  • Regenerative Medicine
  • Biochemistry

Background:

  • Delayed wound healing is a significant global health concern, particularly impacting patients with diabetes and atherosclerosis.
  • Understanding the molecular mechanisms regulating skin repair is crucial for developing effective therapeutic strategies.

Purpose of the Study:

  • To investigate the role of circular RNA circ-Amotl1 in accelerating the skin wound healing process.
  • To elucidate the molecular pathways through which circ-Amotl1 enhances wound repair.

Main Methods:

  • Utilized a mouse excisional wound model to assess the impact of circ-Amotl1 on healing.
  • Employed molecular biology techniques to analyze protein and microRNA expression levels (Stat3, Dnmt3a, miR-17-5p, fibronectin).
  • Investigated protein-protein interactions and subcellular localization (Stat3, Dnmt3a).

Main Results:

  • Ectopic expression of circ-Amotl1 accelerated wound healing in mice.
  • Circ-Amotl1 increased Stat3 and Dnmt3a protein levels.
  • Dnmt3a methylated miR-17 promoter, decreasing miR-17-5p and increasing fibronectin; Stat3 was also a miR-17-5p target.
  • Circ-Amotl1 promoted Stat3 nuclear translocation and interaction with the Dnmt3a promoter, enhancing its transcription.
  • These molecular changes collectively promoted cell adhesion, migration, proliferation, and survival, leading to improved wound repair.

Conclusions:

  • Circular RNA circ-Amotl1 effectively accelerates skin wound healing.
  • The mechanism involves the circ-Amotl1/Stat3/Dnmt3a/miR-17-5p pathway, enhancing cellular repair processes.
  • Ectopic application of circ-Amotl1 shows promise for clinical applications in treating impaired wound healing.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.8K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.0K
Translational Regulation01:29

Translational Regulation

Translational regulation in prokaryotes ensures efficient protein synthesis by controlling ribosome access to mRNA. This regulation is mediated by secondary RNA structures, including translational riboswitches, RNA thermometers, and small RNAs (sRNAs), which respond to intracellular and environmental signals to modulate gene expression.Translational RiboswitchesRiboswitches in the leader region of mRNAs can regulate translation by altering the accessibility of the Shine-Dalgarno (SD) sequence,...
716
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
28.3K